Oncotarget Progress in Research and its role

Oncotarget assured its readers again that all scientific publications will always be available in PubMed, Scopus, Biological Abstracts, Web of Science, BIOSIS Previews and EMBASE. Through a co-operation with the National Library of Medicine, Oncotarget will achieve its aim of becoming the first research journal to submit a whole issue to PubMed few days after online publication.Oncotarget is a biomedical journal is peer-reviewed twice a week that covers research in all fields of oncology and publishes sub-units of on topics that are not related to oncology. These sub-sections include Immunology and Microbiology, Aging, Pathology, Autophagy, Chromosomes and many other areas.

From the time it was established in 2010, the journal has published seven volumes and 324 issues. Currently, the journal is in its eighth volume.In all the published works, the ethics that are recommended by the Committee on Publication must apply. Still, a direct object identifier (DOI) must be given to every publication that is made in the journal. Motivated by the need to solve the 21st challenges, Oncotarget’s mission is to strive to be a journal that is famous for the fast and extensive dissemination of valued biomedical studies. Ultimately, it is a journal that gets managed by scientists and its other for other scientists. It will continue to focus to be a resourceful tool so that it can help all the scientists with their contributions to the growth of science.

The journal seeks to apply clinical and basic medicine to treat, control and prevent diseases. Its aim is that people may live without suffering from any disease.Recently a journal from Oncotarget was published in Research Gate. The research sought to identify and validate any prognostic gene biomarkers to predict survival in patients who have acute myeloid leukemia. From the results, eleven genes significantly associated with the disease got identified. These genes can be used be as markers of the acute myeloid leukemia and proved to be suitable markers for predicting the survival of a suffering the disease. To carry out the study, the researcher screened the gene using a survival package.

Leave a Reply

Your email address will not be published. Required fields are marked *